Effect of Intravenous Fluid therapy on Serum level of Bilirubin in icteric neonates during phototherapy
Not Applicable
- Conditions
- eonatal jaundice.Neonatal jaundice due to unspecified causes
- Registration Number
- IRCT2013022711145N5
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Gestational age > 38 weeks; age > 24 hours on admission; serum level of total bilirubin > 15 mg/dl; indirect hyperbilirubinemia
Exclusion criteria: Necessery to fluid therapy except icter; preterm and LBW neonates; hemolytic jaundice; sepsis; prolonged icter
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubin level. Timepoint: on admission, 6-12-24 hours later. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method Duration of phototherapy. Timepoint: During hospitalization. Method of measurement: Calculating the hours of phototherapy.